← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $577K of Karuna Therapeutics, Inc.

Sold$576,550
$115.31Price
5,000Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Thu, Apr 1. Filed Mon, May 3, 5:10 PM ET, after the close. Not investment advice.